Becker's Healthcare June 14, 2024
It’s unclear how much Mark Cuban can or will disrupt the pharmaceutical industry, but he told The Athletic he’s in the business for the long haul.
For the foreseeable future, he’s willing to deficit spend for his startup Mark Cuban Cost Plus Drug Co., according to the June 14 report.
“We’re not losing that much money,” he told The Athletic, which is part of The New York Times. “And if we keep going the way we’re going, I’ll make a little money. And we’ll use it to add more drugs to our factories, so we can make more.”
After launching Cost Plus Drugs in January 2022 with about 100 generics, the company has grown to sell about 2,500 medications...
Today's Sponsors
Today's Sponsor